Arzodel
Arzodel (Aripiprazole 5–15 mg) — D2 partial-agonist atypical for schizophrenia, bipolar mania, MDD adjunct. low prolactin and weight effects vs other atypicals.
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
⚡ Quick Answer
Arzodel (Aripiprazole 5 / 10 / 15 mg) is an atypical antipsychotic with a unique D2 partial-agonist mechanism. Used for schizophrenia, bipolar mania and maintenance, MDD adjunct, and irritability in autism. Most metabolically clean of the atypicals — minimal weight gain, minimal sedation.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Arzodel at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy — 20-business-day arrival window or we reship at no charge — and qualifies for our customer loyalty programme. Worldwide shipping is available to most destinations.
What Arzodel is and how it works
Arzodel is an aripiprazole tablet supplied by Torrent. Available strengths: 5 / 10 / 15 mg. Aripiprazole is mechanistically distinct from other atypical antipsychotics: it acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and a full antagonist at 5-HT2A receptors. The partial-agonist profile means it functions as an antagonist where dopamine activity is high (treating positive symptoms in schizophrenia) and as a weak agonist where dopamine activity is low (preserving cognition, lowering risk of motor side effects and hyperprolactinaemia).
Indications and dosing
| Indication | Starting | Target | Max |
|---|---|---|---|
| Schizophrenia (adult) | 10–15 mg OD | 10–30 mg OD | 30 mg |
| Schizophrenia (adolescent ≥ 13 y) | 2 mg OD × 2 d → 5 mg × 2 d → 10 mg | 10 mg OD | 30 mg |
| Bipolar mania (adult) | 15 mg OD | 15–30 mg OD | 30 mg |
| MDD adjunct (with antidepressant) | 2–5 mg OD | 5–10 mg OD | 15 mg |
| Autism irritability (≥ 6 y) | 2 mg OD | 5–10 mg OD (weight-based) | 15 mg |
| Tourette syndrome (≥ 6 y) | 2 mg OD | 5–20 mg OD | 20 mg |
Single daily dose, with or without food. Titrate slowly in patients sensitive to akathisia.
Important safety considerations
All atypical antipsychotics carry an FDA black-box warning for increased mortality (mostly cardiovascular and infectious) when used to treat behavioural disturbance in older adults with dementia. Atypicals are not approved for dementia-related psychosis or agitation. Use in this population is off-label, last-resort, time-limited, and requires explicit risk-benefit conversation.
Aripiprazole produces less weight gain, less sedation, and less prolactin elevation than other atypicals — but more akathisia (an inner sense of restlessness, often described as “needing to move”, “skin crawling”, or “can’t sit still”). Akathisia is the most common cause of aripiprazole discontinuation. Manage with dose reduction, propranolol 20–80 mg/day, or switch.
Pathological gambling, hypersexuality, compulsive shopping, and binge eating have been reported on aripiprazole — caused by the partial D2/D3 agonism. Stops on discontinuation. Ask explicitly at follow-up.
When used as an antidepressant adjunct, the under-25 suicidality warning applies.
Common side effects
- Akathisia — most common reason for discontinuation (15–25%).
- Insomnia, anxiety, restlessness — common at initiation; settles in many.
- Nausea, vomiting — first 1–2 weeks.
- Weight gain — modest (less than olanzapine, clozapine, quetiapine).
- Sedation — mild relative to other atypicals.
- Prolactin — usually decreases (D2 partial agonism).
- EPS / tardive dyskinesia — uncommon at usual doses.
Drug interactions
- Strong CYP3A4 inhibitors (azoles, clarithromycin, ritonavir) — halve aripiprazole dose.
- Strong CYP2D6 inhibitors (paroxetine, fluoxetine, bupropion, quinidine) — halve dose.
- Strong CYP3A4 inducers (rifampicin, carbamazepine, phenytoin, St John’s wort) — double dose or switch.
- Other QT-prolonging drugs — generally safer than other atypicals on QT but additive risk possible.
- Antihypertensives — additive hypotension at initiation.
Pregnancy, breastfeeding, paediatric
Pregnancy: limited data; weigh against untreated illness. Breastfeeding: passes into milk; usually compatible with monitoring. Paediatric: licensed from 6 (autism), 10 (bipolar), 13 (schizophrenia).
Storage
Store at 15–30 °C in original packaging.
Frequently Asked Questions
How is Arzodel different from other antipsychotics?
Aripiprazole is the most prescribed dopamine partial agonist (along with brexpiprazole and cariprazine). The clinical translation: less weight gain, less sedation, less prolactin elevation than olanzapine/risperidone/quetiapine — but more akathisia and a small impulse-control disorder signal.
What is akathisia?
Akathisia is an inner sense of restlessness — often described as “needing to move”, “skin crawling”, or “can’t sit still”. It is the most common reason patients stop aripiprazole. Tell your prescriber early — it’s manageable with dose reduction, propranolol 20–80 mg/day, or sometimes a benzodiazepine bridge while the dose is titrated.
Will Arzodel make me gain weight?
Modest weight gain — typically 1–3 kg over 6 months, much less than olanzapine, clozapine, or quetiapine. Aripiprazole is often the atypical of choice when weight is a primary concern.
Can Arzodel be used with an antidepressant?
Yes — aripiprazole is FDA-approved as an adjunct to antidepressants in major depression at low doses (2–10 mg). Combination is well-evidenced (CO-MED, others) and well-tolerated.
Why does Arzodel sometimes cause gambling or other compulsions?
The D2/D3 partial agonism extends to limbic reward circuits. A small subset of patients develops impulse-control disorders (pathological gambling, hypersexuality, compulsive shopping, binge eating). Always asked explicitly at follow-up. Stops on discontinuation.
How long until Arzodel works?
Antipsychotic effect usually visible within 1–2 weeks for positive symptoms; full effect at 4–6 weeks. Antidepressant adjunct effect at 2–6 weeks. Mood-stabilising effect in bipolar within days for acute mania.
Can Arzodel be stopped abruptly?
Generally yes — withdrawal is mild because of aripiprazole’s long half-life (~75 hours). However, abrupt cessation in schizophrenia and bipolar carries a high relapse risk. Never stop without prescriber agreement.
Will Arzodel affect my fertility?
Aripiprazole rarely raises prolactin — fertility is not usually affected. Compare risperidone (raises prolactin substantially, common cause of amenorrhoea, galactorrhoea, and male hypogonadism).
What about driving on Arzodel?
Sedation is relatively mild. Most patients on stable doses drive normally — but the first 1–2 weeks of titration may impair reaction time. Avoid driving until tolerability is known.
Are LAI (long-acting injectable) versions available?
Yes — depot aripiprazole formulations (Maintena monthly, Asimtufii bimonthly) are available for adherence support in schizophrenia. The oral tablet version is the standard initiation and dose-titration formulation.
Other Mental Health Medications
- Aripicon (Aripiprazole — D2 partial agonist)
- Olanzap (Olanzapine — robust antipsychotic)
- Risdone (Risperidone)
- Seroquit (Quetiapine — bipolar depression)
- Atlura (Lurasidone — metabolically clean)
More options in Mental Health and Psychiatric Medications
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 15 mg |
|---|---|
| Quantity | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s |
Arzodel
Q & A
Arzodel
Related products
Reviews
There are no reviews yet